InnovationAug 14, 2026Choice for Women: Reimagining birth control on Eindhoven's innovation groundIn a groundbreaking move for reproductive health, Eindhoven's Choice for Women has unveiled a new, non-hormonal birth control device.
InnovationAug 14, 2026Choice for Women: Reimagining birth control on Eindhoven's innovation groundIn a groundbreaking move for reproductive health, Eindhoven's Choice for Women has unveiled a new, non-hormonal birth control device.
InnovationAug 14, 2026Choice for Women: Reimagining birth control on Eindhoven's innovation groundIn a groundbreaking move for reproductive health, Eindhoven's Choice for Women has unveiled a new, non-hormonal birth control device.
InnovationConfo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate
InnovationConfo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate
InnovationConfo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate
InnovationKhondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease
InnovationKhondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease
InnovationKhondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease
CareerFrom Bench to Business: What a Week at the BioBusiness Summer School Taught Me About My Own Value
CareerFrom Bench to Business: What a Week at the BioBusiness Summer School Taught Me About My Own Value
CareerFrom Bench to Business: What a Week at the BioBusiness Summer School Taught Me About My Own Value
